1985 Volume 76 Issue 8 Pages 1138-1147
Eighty-three cases of adult non-seminomatous testicular cancer were treated at the Department of Urology, National Cancer Center Hospital, Tokyo, from 1962 to August, 1984.
The three year survival rate was 100% for Stage I and IIa (8 cases), 0% for Stage IIb (2 cases) and 25.9% for Stage III (13 cases) from 1978 to 1984, whereas it was 49.8% for Stage I (29 cases), 0% for Stage IIa (2 cases), 25% for Stage IIb (8 cases) and 4.8% Stage III (21 cases) before 1978.
Improvement of the survival rates after 1978 are due to the development of accurate staging methods such as tumor marker, CT-scan and ultrasonography and effective chemotherapy.
However, of 13 cases of Stage III from 1978 to 1984, only 1 patient had complete remission by chemotherapy. Therefore, cytoreductive surgery after chemotherapy appears essential for successful management of stage III testicular cancer.